Neuropathology
10
5
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Cognitive Functioning in Adults With Somatic Diseases and General Population From a Biopsychosocial Perspective
Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline?
Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease
Neuropathological Changes of the Intestinal Wall in Patients With Bowel Evacuation Disorders
Idiopathic Generalized Epilepsy Cognitive and Emotional Profile
Development of a Point of Care System for Automated Coma Prognosis
Artificial Intelligence Neuropathologist
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Prospective Study Evaluating the Interest of Long-term Cardiac Recording in Cerebral Infarction
Assessment of the Prevalence of Small Fiber Peripheral Neuropathy Among Non-diabetic Obese Patients